Jefferies Upgrades QuidelOrtho’s Outlook from Hold to Buy

Fintel reports that on May 8, 2025, Jefferies upgraded their outlook for QuidelOrtho (BMV:QDEL1) from Hold to Buy.

Current Fund Sentiment

As of now, there are two funds or institutions reporting positions in QuidelOrtho, a figure that has remained unchanged over the last quarter. Notably, the average portfolio weight dedicated to QDEL1 from all funds is 0.01%, marking an increase of 48.19%.

Actions of Other Shareholders

T. Rowe Price Investment Management currently holds 11,239K shares, up from 9,398K shares reported in its previous filing. This change signifies a 16.38% increase, as the firm expanded its portfolio allocation in QDEL1 by 19.52% over the last quarter.

Rubric Capital Management has increased its holdings to 5,550K shares, up from 4,200K shares in the prior quarter, which represents a 24.32% increase. Their portfolio allocation in QDEL1 also rose by 1.68%.

The IJR – iShares Core S&P Small-Cap ETF now holds 4,253K shares, up from 3,688K shares previously, indicating a 13.29% increase. This firm has raised its portfolio allocation in QDEL1 by 10.86% over the last quarter.

Invesco has reported a substantial increase in shares held, now owning 3,447K shares compared to 2,008K shares in its prior filing, which constitutes a 41.75% increase. The overall portfolio allocation in QDEL1 surged by 60.60%.

Lastly, RPMGX – T. Rowe Price Mid-Cap Growth Fund currently holds 3,265K shares, a slight decrease from 3,280K shares in its previous filing, reflecting a 0.43% drop. Despite this, the firm slightly increased its portfolio allocation in QDEL1 by 0.79% over the past quarter.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.